Ferring, Aventis Trim Claims In DDAVP Antitrust Class Action
A New York federal judge on Wednesday narrowed claims brought by a proposed class of indirect purchasers of the anti-diuretic drug DDAVP who allege Ferring BV and a Sanofi SA unit...To view the full article, register now.
Already a subscriber? Click here to view full article